Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Differential dopamine function in fibromyalgia.

Albrecht DS, MacKie PJ, Kareken DA, Hutchins GD, Chumin EJ, Christian BT, Yoder KK.

Brain Imaging Behav. 2016 Sep;10(3):829-39. doi: 10.1007/s11682-015-9459-4.

2.

Cortical dopamine release during a behavioral response inhibition task.

Albrecht DS, Kareken DA, Christian BT, Dzemidzic M, Yoder KK.

Synapse. 2014 Jun;68(6):266-74. doi: 10.1002/syn.21736. Epub 2014 Feb 28.

3.

Relation of dopamine receptor 2 binding to pain perception in female fibromyalgia patients with and without depression--A [¹¹C] raclopride PET-study.

Ledermann K, Jenewein J, Sprott H, Hasler G, Schnyder U, Warnock G, Johayem A, Kollias S, Buck A, Martin-Soelch C.

Eur Neuropsychopharmacol. 2016 Feb;26(2):320-330. doi: 10.1016/j.euroneuro.2015.12.007. Epub 2015 Dec 10.

PMID:
26708319
4.

Working memory performance is correlated with local brain morphology in the medial frontal and anterior cingulate cortex in fibromyalgia patients: structural correlates of pain-cognition interaction.

Luerding R, Weigand T, Bogdahn U, Schmidt-Wilcke T.

Brain. 2008 Dec;131(Pt 12):3222-31. doi: 10.1093/brain/awn229. Epub 2008 Sep 26.

PMID:
18819988
5.

Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.

Narendran R, Frankle WG, Mason NS, Rabiner EA, Gunn RN, Searle GE, Vora S, Litschge M, Kendro S, Cooper TB, Mathis CA, Laruelle M.

Synapse. 2009 Jun;63(6):447-61. doi: 10.1002/syn.20628.

PMID:
19217025
6.

Changes in gray matter density in fibromyalgia: correlation with dopamine metabolism.

Wood PB, Glabus MF, Simpson R, Patterson JC 2nd.

J Pain. 2009 Jun;10(6):609-18. doi: 10.1016/j.jpain.2008.12.008. Epub 2009 Apr 23.

PMID:
19398377
7.

Placebo analgesia: Self-report measures and preliminary evidence of cortical dopamine release associated with placebo response.

Jarcho JM, Feier NA, Labus JS, Naliboff B, Smith SR, Hong JY, Colloca L, Tillisch K, Mandelkern MA, Mayer EA, London ED.

Neuroimage Clin. 2015 Nov 14;10:107-14. doi: 10.1016/j.nicl.2015.11.009. eCollection 2016.

8.

Fibromyalgia patients show an abnormal dopamine response to pain.

Wood PB, Schweinhardt P, Jaeger E, Dagher A, Hakyemez H, Rabiner EA, Bushnell MC, Chizh BA.

Eur J Neurosci. 2007 Jun;25(12):3576-82.

PMID:
17610577
9.

D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia.

Buchsbaum MS, Christian BT, Lehrer DS, Narayanan TK, Shi B, Mantil J, Kemether E, Oakes TR, Mukherjee J.

Schizophr Res. 2006 Jul;85(1-3):232-44. Epub 2006 May 19.

PMID:
16713185
10.

Chronic Back Pain Is Associated with Alterations in Dopamine Neurotransmission in the Ventral Striatum.

Martikainen IK, Nuechterlein EB, Peciña M, Love TM, Cummiford CM, Green CR, Stohler CS, Zubieta JK.

J Neurosci. 2015 Jul 8;35(27):9957-65. doi: 10.1523/JNEUROSCI.4605-14.2015.

11.

A positron emission tomography (PET) investigation of the role of striatal dopamine (D2) receptor availability in spatial cognition.

Reeves SJ, Grasby PM, Howard RJ, Bantick RA, Asselin MC, Mehta MA.

Neuroimage. 2005 Oct 15;28(1):216-26. Epub 2005 Jun 24.

PMID:
15979345
12.

Executive function in chronic pain patients and healthy controls: different cortical activation during response inhibition in fibromyalgia.

Glass JM, Williams DA, Fernandez-Sanchez ML, Kairys A, Barjola P, Heitzeg MM, Clauw DJ, Schmidt-Wilcke T.

J Pain. 2011 Dec;12(12):1219-29. doi: 10.1016/j.jpain.2011.06.007. Epub 2011 Sep 25.

13.

[18F]Fallypride PET measurement of striatal and extrastriatal dopamine D 2/3 receptor availability in recently abstinent alcoholics.

Rominger A, Cumming P, Xiong G, Koller G, Böning G, Wulff M, Zwergal A, Förster S, Reilhac A, Munk O, Soyka M, Wängler B, Bartenstein P, la Fougère C, Pogarell O.

Addict Biol. 2012 Mar;17(2):490-503. doi: 10.1111/j.1369-1600.2011.00355.x. Epub 2011 Oct 3.

PMID:
22023291
14.

Spinal cord dopamine D2/D3 receptors: in vivo and ex vivo imaging in the rat using (18)F/(11)C-fallypride.

Kaur J, Khararjian A, Coleman RA, Constantinescu CC, Pan ML, Mukherjee J.

Nucl Med Biol. 2014 Nov-Dec;41(10):841-7. doi: 10.1016/j.nucmedbio.2014.08.002. Epub 2014 Aug 8.

15.

DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls.

Potvin S, Larouche A, Normand E, de Souza JB, Gaumond I, Grignon S, Marchand S.

J Pain. 2009 Sep;10(9):969-75. doi: 10.1016/j.jpain.2009.03.013. Epub 2009 May 23.

PMID:
19464960
16.

Cerebral morphology and dopamine D2/D3 receptor distribution in humans: a combined [18F]fallypride and voxel-based morphometry study.

Woodward ND, Zald DH, Ding Z, Riccardi P, Ansari MS, Baldwin RM, Cowan RL, Li R, Kessler RM.

Neuroimage. 2009 May 15;46(1):31-8. doi: 10.1016/j.neuroimage.2009.01.049. Epub 2009 Feb 5. Erratum in: Neuroimage. 2009 Oct 1;47(4):2090.

17.

Electroencephalographic Evidence of Altered Top-Down Attentional Modulation in Fibromyalgia Patients During a Working Memory Task.

González-Villar AJ, Pidal-Miranda M, Arias M, Rodríguez-Salgado D, Carrillo-de-la-Peña MT.

Brain Topogr. 2017 Jul;30(4):539-547. doi: 10.1007/s10548-017-0561-3. Epub 2017 Apr 10.

PMID:
28397030
18.

18F-fallypride PET-CT of dopamine D2/D3 receptors in patients with sporadic amyotrophic lateral sclerosis.

Fu X, Zhu W, Guo Z, Shu G, Cui F, Yang F, Zhang Y, Ren Y, Zhang X, Zhang X, Chen Z, Ling L, Huang X, Zhang J.

J Neurol Sci. 2017 Jun 15;377:79-84. doi: 10.1016/j.jns.2017.03.013. Epub 2017 Mar 10.

PMID:
28477714
19.

High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol.

Vandehey NT, Moirano JM, Converse AK, Holden JE, Mukherjee J, Murali D, Nickles RJ, Davidson RJ, Schneider ML, Christian BT.

J Cereb Blood Flow Metab. 2010 May;30(5):994-1007. doi: 10.1038/jcbfm.2009.270. Epub 2009 Dec 30.

20.

Measuring dopamine neuromodulation in the thalamus: using [F-18]fallypride PET to study dopamine release during a spatial attention task.

Christian BT, Lehrer DS, Shi B, Narayanan TK, Strohmeyer PS, Buchsbaum MS, Mantil JC.

Neuroimage. 2006 May 15;31(1):139-52. Epub 2006 Feb 8.

PMID:
16469510

Supplemental Content

Support Center